Literature DB >> 4275615

Trimethoprim action and its analogy with thymine starvation.

S G Amyes, J T Smith.   

Abstract

In a minimal medium, trimethoprim is merely bacteriostatic on the prototroph Escherichia coli 114. The drug was bactericidal when the amino acids methionine and glycine, plus a purine or purine nucleoside, were also present. This response could be reversed completely when thymine and lysine were added to the culture. Methionine, glycine, and the purine are thought to maintain the integrity of the tetrahydrofolate pool under trimethoprim treatment and prevent the thymidylate synthetase reaction. Thus, the organism behaves phenotypically as a thymineless mutant. The mechanisms by which thymine and lysine reverse the bactericidal effect of trimethoprim in a minimal medium containing methionine, glycine, and adenine is discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4275615      PMCID: PMC428939          DOI: 10.1128/AAC.5.2.169

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI.

Authors:  K A STACEY; E SIMSON
Journal:  J Bacteriol       Date:  1965-08       Impact factor: 3.490

2.  Massive incorporation of 5-fluorouracil into a bacterial ribonucleic acid.

Authors:  J HOROWITZ; E CHARGAFF
Journal:  Nature       Date:  1959-10-17       Impact factor: 49.962

3.  The induction of thymine synthesis by T2 infection of a thymine requiring mutant of Escherichia coli.

Authors:  H D BARNER; S S COHEN
Journal:  J Bacteriol       Date:  1954-07       Impact factor: 3.490

4.  THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES.

Authors:  S S Cohen; J G Flaks; H D Barner; M R Loeb; J Lichtenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

5.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

6.  Effects of trimethoprim on Escherichia coli under limited nutrition.

Authors:  R Then; P Angehrn
Journal:  Arzneimittelforschung       Date:  1973-03

7.  The role of nucleoside phosphorylases in the degradation of deoxyribonucleosides by thymine-requiring mutants of E. coli.

Authors:  I R Beacham; R H Pritchard
Journal:  Mol Gen Genet       Date:  1971

8.  Species differences among dihydrofolate reductases as a basis for chemotherapy.

Authors:  G H Hitchings
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

9.  The relation of resistance transfer factors to the F-factor (sex-factor) of Escherichia coli K12.

Authors:  E Meynell; N Datta
Journal:  Genet Res       Date:  1966-02       Impact factor: 1.588

10.  Growth and initiation of protein synthesis in Escherichia coli in the presence of trimethoprim.

Authors:  R J Harvey
Journal:  J Bacteriol       Date:  1973-04       Impact factor: 3.490

View more
  21 in total

1.  Influence of specific mutations on the thermal stability of the td group I intron in vitro and on its splicing efficiency in vivo: a comparative study.

Authors:  P Brion; R Schroeder; F Michel; E Westhof
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

2.  Unusual expression of new low-level-trimethoprim-resistance plasmids.

Authors:  H K Young; M V Jesudason; G Koshi; S G Amyes
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

3.  Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

4.  Topoisomerase I function during Escherichia coli response to antibiotics and stress enhances cell killing from stabilization of its cleavage complex.

Authors:  I-Fen Liu; Jeanette H Sutherland; Bokun Cheng; Yuk-Ching Tse-Dinh
Journal:  J Antimicrob Chemother       Date:  2011-04-11       Impact factor: 5.790

5.  Co-trimoxazole or trimethoprim alone? A viewpoint on their relative place in therapy.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

6.  Bactericidal or bacteristatic effects of two sulphonamide plus trimethoprim preparations in human urine.

Authors:  J M Broughall; M J Bywater; H A Holt; D S Reeves
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  Role of purine biosynthetic intermediates in response to folate stress in Escherichia coli.

Authors:  C E Rohlman; R G Matthews
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

8.  In Vivo Titration of Folate Pathway Enzymes.

Authors:  Deepika Nambiar; Timkhite-Kulu Berhane; Robert Shew; Bryan Schwarz; Michael R Duff; Elizabeth E Howell
Journal:  Appl Environ Microbiol       Date:  2018-09-17       Impact factor: 4.792

9.  Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.

Authors:  S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

10.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.